look news india
Monkeypox in Europe and Asia After the entry of Corona virus, the fear of this disease is increasing a lot. The World Health Organization has also expressed concern about this. Many experts believe that in the coming times, this can prove to be as dangerous as the corona virus epidemic.
This medicine for monkeypox is proving ineffective
However, now worrying news is coming out about its medicine. Scientists have informed that the antiviral drug Tecovirimat is not effective on the Clade-1 strain of monkeypox. At present, this strain is spreading rapidly. The previous wave of monkeypox was controlled with the help of the drug Tecovirimat.
'Wounds are not healing'
According to scientists, new research has shown that when the antiviral drug tecovirimat is applied to the lesions of the Clade-1 strain, it has no significant effect. This drug is also known as TPOXX. Scientists are also investigating whether it is able to reduce the duration of the effect of monkeypox in children and adults in the Democratic Republic of Congo. The Clade-1 strain of the monkeypox virus has been wreaking havoc in this country since September 2023.
This medicine was made for smallpox
Talking about the history of the drug Tecovirimat, it was developed to treat smallpox. This drug was approved by the US Food and Drug Administration. Monkeypox and smallpox are very similar, but monkeypox is more dangerous than smallpox. Research conducted at the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health has found that the drug Tecovirimat is safe, but the health of people suffering from the Clade-1 strain is not improving.
